Published in J Mol Diagn on December 10, 2009
Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi. J Clin Microbiol (2011) 0.93
New strategy for rapid diagnosis and characterization of fungal infections: the example of corneal scrapings. PLoS One (2012) 0.85
Rapid identification of medically important Candida isolates using high resolution melting analysis. PLoS One (2015) 0.81
Molecular diagnostics for invasive fungal infections: a call for refinement and implementation. J Mol Diagn (2009) 0.78
Development of Candida-Specific Real-Time PCR Assays for the Detection and Identification of Eight Medically Important Candida Species. Microbiol Insights (2016) 0.77
Dynamic time warping assessment of high-resolution melt curves provides a robust metric for fungal identification. PLoS One (2017) 0.75
Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles. J Clin Microbiol (2015) 0.75
Microbial Typing by Machine Learned DNA Melt Signatures. Sci Rep (2017) 0.75
Principles of a New Protocol for Prediction of Azole Resistance in Candida albicans Infections on the Basis of ERG11 Polymorphisms. Curr Microbiol (2016) 0.75
The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol (1987) 266.90
MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol (2007) 168.76
Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci U S A (2004) 20.53
The diploid genome sequence of Candida albicans. Proc Natl Acad Sci U S A (2004) 6.34
Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system. J Clin Microbiol (2000) 3.02
Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol (1995) 2.75
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia (2001) 2.64
Rapid identification of Candida species in blood cultures by a clinically useful PCR method. J Clin Microbiol (1997) 2.46
Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol (2006) 2.41
Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol (2002) 2.31
Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species. Yeast (1993) 2.26
Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol (2006) 2.15
Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans. J Clin Microbiol (1991) 2.12
Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles. J Clin Microbiol (2002) 2.11
Treatment of zygomycosis: current and new options. J Antimicrob Chemother (2008) 1.86
Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry. Ann N Y Acad Sci (2007) 1.79
Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn Microbiol Infect Dis (2006) 1.72
DNA and the classical way: identification of medically important molds in the 21st century. Med Mycol (2007) 1.69
Sequence analysis of the internal transcribed spacer 2 (ITS2) from yeast species within the genus Candida. Curr Microbiol (1998) 1.64
Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures. J Clin Microbiol (2005) 1.60
Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev (2002) 1.59
Simple and rapid detection of Candida albicans DNA in serum by PCR for diagnosis of invasive candidiasis. J Clin Microbiol (2000) 1.58
Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes. J Clin Microbiol (1999) 1.56
Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo. J Clin Microbiol (2002) 1.49
Towards understanding the evolution of the human commensal yeast Candida albicans. Microbiology (1999) 1.49
Rapid detection and identification of Candida, Aspergillus, and Fusarium species in ocular samples using nested PCR. J Clin Microbiol (2000) 1.46
Rapid identification of Candida dubliniensis using a species-specific molecular beacon. J Clin Microbiol (2000) 1.34
Rapid identification of candida species by TaqMan PCR. J Clin Pathol (2001) 1.33
Galactomannan antigen detection in the diagnosis of invasive aspergillosis. Expert Rev Mol Diagn (2007) 1.29
Species identification of medically important fungi by use of real-time LightCycler PCR. J Med Microbiol (2003) 1.26
Pathogenicity and drug resistance in Candida albicans and other yeast species. A review. Acta Microbiol Immunol Hung (2007) 1.25
Unlabeled oligonucleotides as internal temperature controls for genotyping by amplicon melting. J Mol Diagn (2007) 1.23
Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods. Oral Microbiol Immunol (2003) 1.18
Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol (2007) 1.18
In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Br J Dermatol (2003) 1.18
Rapid identification of commonly encountered Candida species directly from blood culture bottles. J Clin Microbiol (2003) 1.17
A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J Mol Diagn (2006) 1.16
Simultaneous detection and identification of Candida, Aspergillus, and Cryptococcus species by reverse line blot hybridization. J Clin Microbiol (2006) 1.12
Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron. J Clin Microbiol (2001) 1.12
Detection of Candida in concentrated oral rinse cultures by real-time PCR. J Clin Microbiol (2004) 1.11
Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol (2006) 1.10
A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol (2007) 1.09
Reverse line blot hybridization assay for identification of medically important fungi from culture and clinical specimens. J Clin Microbiol (2007) 1.05
The Pan-AC assay: a single-reaction real-time PCR test for quantitative detection of a broad range of Aspergillus and Candida species. J Med Microbiol (2007) 1.05
Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host. Transpl Infect Dis (2006) 1.02
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest. Antimicrob Agents Chemother (2006) 0.98
Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections. J Clin Pathol (2002) 0.93
Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients. Med Mycol (2006) 0.92
Multiplex PCR identification of eight clinically relevant Candida species. Med Mycol (2007) 0.90
Specific identification of Candida albicans by hybridization with oligonucleotides derived from ribosomal DNA internal spacers. Yeast (1994) 0.89
Fluconazole-resistant pathogens Candida inconspicua and C. norvegensis: DNA sequence diversity of the rRNA intergenic spacer region, antifungal drug susceptibility, and extracellular enzyme production. Microbiol Immunol (2004) 0.88
Genetic identification of Candida species in HIV-positive patients using the polymerase chain reaction and restriction fragment length polymorphism analysis of its DNA. Mol Cell Probes (1999) 0.88
Identification of species of the genus Candida by analysis of the 5.8S rRNA gene and the two ribosomal internal transcribed spacers. Antonie Van Leeuwenhoek (2004) 0.88
Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCR. J Med Microbiol (2007) 0.88
Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting. J Clin Microbiol (2005) 0.87
Fungal diagnostics: current techniques and future trends. Vet Clin North Am Small Anim Pract (2007) 0.86
Comparison of galactomannan detection, PCR-enzyme-linked immunosorbent assay, and real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model and effect of caspofungin acetate. Clin Diagn Lab Immunol (2005) 0.86
Genetic diversity of the internal transcribed spacers (ITS) and 5.8S rRNA genes among the clinical isolates of Candida parapsilosis in Brazil and Japan. Nihon Ishinkin Gakkai Zasshi (2005) 0.86
Rapid identification of Debaryomyces hansenii/Candida famata by polymerase chain reaction. Med Mycol (1999) 0.85
Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression. Antimicrob Agents Chemother (2005) 0.85
Rapid identification of Candida albicans, C. glabrata, C. parapsilosis and C. krusei by species-specific PCR of large subunit ribosomal DNA. J Med Microbiol (1996) 0.85
Use of DNA microarray technology and gene expression profiles to investigate the pathogenesis, cell biology, antifungal susceptibility and diagnosis of Candida albicans. FEMS Yeast Res (2006) 0.84
Molecular and phenotypic identification of the yeast pathogen Candida dubliniensis. J Mol Med (Berl) (2000) 0.83
Single primer pair for PCR identification of Candida parapsilosis group I isolates. J Med Microbiol (2001) 0.82
First reported case of endocarditis caused by Candida dubliniensis. J Clin Microbiol (2005) 0.81
Antifungal resistance in Aspergillus. Med Mycol (2005) 0.81
Development and validation of a molecular method for the diagnosis of medically important fungal infections. New Microbiol (2007) 0.81
Antifungal therapy--state of the art at the beginning of the 21st century. Prog Drug Res (2003) 0.80
Diagnostics of fungal infections in the Nordic countries: we still need to improve! Scand J Infect Dis (2007) 0.79
Molecular identification of Candida parapsilosis from crop mucosa in a cockatiel. J Vet Diagn Invest (2001) 0.78
[Biological diagnosis of systemic candidiasis: difficulties and future prospects]. Pathol Biol (Paris) (2006) 0.77
Laboratory diagnosis and therapy of invasive fungal infections. Curr Drug Targets (2006) 0.77
Explorative screening of complex microbial communities by real-time 16S rDNA restriction fragment melting curve analyses. Biotechniques (2005) 0.76
Candida digboiensis sp. nov., a novel anamorphic yeast species from an acidic tar sludge-contaminated oilfield. Int J Syst Evol Microbiol (2005) 0.76
Rapid identification and classification of bacteria by 16S rDNA restriction fragment melting curve analyses (RFMCA). Food Microbiol (2006) 0.76
Evaluation of internal transcribed spacer region of ribosomal DNA sequence analysis for molecular characterization of Candida albicans and Candida dubliniensis isolates from HIV-infected patients. Med Mycol (2002) 0.76
Candida asparagi sp. nov., Candida diospyri sp. nov. and Candida qinlingensis sp. nov., novel anamorphic, ascomycetous yeast species. Int J Syst Evol Microbiol (2004) 0.76
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 18.19
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis (2010) 11.65
Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis (2008) 6.21
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis (2012) 5.83
Guidelines for treatment of candidiasis. Clin Infect Dis (2003) 5.55
Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med (2008) 3.36
Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol (2002) 3.03
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis (2009) 2.53
Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens. J Mol Diagn (2013) 2.27
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis (2014) 1.78
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.69
Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med (2006) 1.66
Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. Clin Infect Dis (2009) 1.63
Effect of antibiotics on vulvovaginal candidiasis: a MetroNet study. J Am Board Fam Med (2008) 1.61
Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis (2010) 1.59
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. Clin Infect Dis (2005) 1.56
Uropathogenic Escherichia coli are more likely than commensal E. coli to be shared between heterosexual sex partners. Am J Epidemiol (2002) 1.44
Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. Am J Obstet Gynecol (2004) 1.44
Anidulafungin: a novel echinocandin. Clin Infect Dis (2006) 1.41
Validation data-based adjustments for outcome misclassification in logistic regression: an illustration. Epidemiology (2011) 1.35
Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety. Clin Infect Dis (2010) 1.32
Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis (2013) 1.30
Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis (2002) 1.29
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.28
Trichomonas vaginalis genital infections: progress and challenges. Clin Infect Dis (2011) 1.22
Ocular manifestations of candidemia. Clin Infect Dis (2011) 1.22
Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses (2011) 1.20
Candida urinary tract infections--treatment. Clin Infect Dis (2011) 1.18
Candida urinary tract infection: pathogenesis. Clin Infect Dis (2011) 1.16
Mucosal candidiasis. Infect Dis Clin North Am (2002) 1.12
Discordance between spermatozoa detection and self-reported semen exposure. Sex Transm Dis (2011) 1.11
Bacterial vaginosis: culture- and PCR-based characterizations of a complex polymicrobial disease's pathobiology. Curr Infect Dis Rep (2007) 1.07
Candida urinary tract infections--diagnosis. Clin Infect Dis (2011) 1.05
Emerging azole antifungals. Expert Opin Emerg Drugs (2005) 1.04
Fluconazole-resistant Candida albicans vulvovaginitis. Obstet Gynecol (2012) 1.04
Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis (2004) 1.04
Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium. Antimicrob Agents Chemother (2004) 1.03
Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies. Curr Med Res Opin (2014) 1.03
Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG (2011) 0.99
Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin. Infect Dis Clin North Am (2004) 0.98
Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy. Clin Infect Dis (2002) 0.96
Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis. Sex Transm Dis (2009) 0.95
Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin. Infect Dis Clin North Am (2009) 0.94
MRSA infection of buttocks, vulva, and genital tract in women. Curr Infect Dis Rep (2009) 0.94
Bacterial vaginosis and the natural history of human papillomavirus. Infect Dis Obstet Gynecol (2011) 0.93
Group B Streptococcus infections in non-pregnant adults: the role of immunosuppression. Int J Infect Dis (2012) 0.92
Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women. J Med Microbiol (2011) 0.92
Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights. Curr Infect Dis Rep (2010) 0.91
Growing prevalence of Providencia stuartii associated with the increased usage of colistin at a tertiary health care center. Int J Infect Dis (2012) 0.91
Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use. Antimicrob Agents Chemother (2012) 0.90
Antifungal drugs in pregnancy: a review. Expert Opin Drug Saf (2003) 0.90
Clostridium difficile colitis: a review. Hosp Pract (1995) (2012) 0.89
The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women. Sex Transm Dis (2011) 0.89
Changing epidemiology of invasive candidiasis in intensive care units--much ado about nothing? Crit Care Med (2008) 0.88
Genital mycotic infections in patients with diabetes. Postgrad Med (2013) 0.88
Shuttle vectors for Candida albicans: control of plasmid copy number and elevated expression of cloned genes. Curr Genet (2004) 0.88
ELISA versus conventional methods of diagnosing endemic brucellosis. Am J Trop Med Hyg (2010) 0.87
Vulvovaginal candidiasis: a comparison of HIV-positive and -negative women. Int J STD AIDS (2002) 0.87
Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severity. Obstet Gynecol (2003) 0.87
Vulvovaginal candidiasis. Obstet Gynecol Clin North Am (2003) 0.86
Echinocandins--first-choice or first-line therapy for invasive candidiasis? N Engl J Med (2007) 0.85
Association between semen exposure and incident bacterial vaginosis. Infect Dis Obstet Gynecol (2011) 0.85
Metronidazole for the treatment of vaginal infections. Expert Opin Pharmacother (2015) 0.82
Persistence of intracellular bacteria in the urinary bladder. Clin Infect Dis (2013) 0.82
Use of terbinafine in rare and refractory mycoses. Future Microbiol (2008) 0.82
Fluconazole for the treatment of candidiasis: 15 years experience. Expert Rev Anti Infect Ther (2004) 0.81
Guidelines for the treatment of bacterial vaginosis: focus on tinidazole. Ther Clin Risk Manag (2009) 0.81
Fungal endocarditis. Curr Infect Dis Rep (2008) 0.81
Accuracy of clinical diagnosis of bacterial vaginosis by human immunodeficiency virus infection status. Sex Transm Dis (2011) 0.81
Candida glabrata complicating in vitro pregnancy: successful management of subsequent pregnancy. Fertil Steril (2010) 0.80
The VI-SENSE-vaginal discharge self-test to facilitate management of vaginal symptoms. Am J Obstet Gynecol (2006) 0.80
High-dose vaginal maintenance metronidazole for recurrent bacterial vaginosis: a pilot study. Sex Transm Dis (2014) 0.80
Pharmacokinetics and monte carlo simulations of doripenem in patients with febrile neutropenia. Ann Pharmacother (2012) 0.80
Valvular perforation in left-sided native valve infective endocarditis. Clin Cardiol (2009) 0.80
Vulvovaginal trichosporonosis. Infect Dis Obstet Gynecol (2003) 0.80
Tinidazole for bacterial vaginosis. Expert Rev Anti Infect Ther (2007) 0.79
Novel PCR-based methods enhance characterization of vaginal microbiota in a bacterial vaginosis patient before and after treatment. Appl Environ Microbiol (2013) 0.79
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis. Sex Transm Dis (2015) 0.79
Coughing spells in a Michiganian girl after a trip to Southwest US. Pediatr Infect Dis J (2015) 0.78
Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy. Diagn Microbiol Infect Dis (2009) 0.78
Tinidazole for the treatment of vaginal infections. Expert Opin Investig Drugs (2007) 0.78
Antibiotics for gram-positive bacterial infection: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, telavancin, and ceftaroline. Med Clin North Am (2011) 0.78
Candida Vulvovaginitis in Pregnancy. Curr Infect Dis Rep (2004) 0.78
Candida kefyr endocarditis in a patient with hypertrophic obstructive cardiomyopathy. Am J Med Sci (2010) 0.78
Lack of association of herpes simplex virus type 2 seropositivity with the progression of HIV infection in the HERS cohort. Am J Epidemiol (2011) 0.78
Sepsis associated with a new Atopobium species, provisionally named Atopobium detroiti: case report and review of the current status of the species Atopobium. Scand J Infect Dis (2008) 0.78
Septic shock due to candidemia: outcomes and predictors of shock development. J Clin Med Res (2011) 0.77
Miconazole mucoadhesive tablets: a novel delivery system. Clin Infect Dis (2012) 0.77
Douching for perceived vaginal odor with no infectious cause of vaginitis: a randomized controlled trial. J Low Genit Tract Dis (2011) 0.77
Desquamative inflammatory vaginitis: an exploratory case-control study. Ann Epidemiol (2002) 0.77
Failure of nitazoxanide to cure trichomoniasis in three women. Sex Transm Dis (2007) 0.76
High-dose vaginal metronidazole for recurrent bacterial vaginosis--a pilot study. J Low Genit Tract Dis (2014) 0.76
Onset of vulvodynia in a woman ultimately diagnosed with Creutzfeldt-Jakob disease. Obstet Gynecol (2010) 0.76